No Data
No Data
Eupraxia Pharmaceuticals Showcases Innovative Drug Delivery
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo
VICTORIA, BC, July 8, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
Press Release: Eupraxia Pharmaceuticals Announces Voting Results From Annual General and Special Meeting of Shareholders
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders PR Newswire VICTORIA, BC, June 6, 2024 VICTORIA, BC, June 6, 2024 /PRNewswire/ - Eupraxia P
Express News | Eupraxia Pharmaceuticals To Present Results From Its Phase 2 Study Of EP-104IAR For The Treatment Of Osteoarthritis Of The Knee At European Rheumatology Congress 2024
Eupraxia Pharmaceuticals to Present Data From the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
VICTORIA, BC, June 5, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage...
No Data